Bioorganic & Medicinal Chemistry Letters 2018-03-28

Erratum to “Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes” Bioorg. Med. Chem. Lett. 28 (2018) [841–846]

Michael P. Winters, Zhihua Sui, Mark Wall, Yuanping Wang, Joseph Gunnet, James Leonard, Hong Hua, Wen Yan, Arthur Suckow, Austin Bell, Wilmelenne Clapper, Celia Jenkinson, Peter Haug, Tatiana Koudriakova, Norman Huebert, William V. Murray

Index: 10.1016/j.bmcl.2018.03.053

Full Text: HTML

Abstract

Latest Articles:

Design, synthesis, evaluation, and molecular docking of ursolic acid derivatives containing a nitrogen heterocycle as anti-inflammatory agents

2018-04-11

[10.1016/j.bmcl.2018.04.021]

Covalent inhibitors of nicotinamide N-methyltransferase (NNMT) provide evidence for target engagement challenges in situ

2018-04-10

[10.1016/j.bmcl.2018.04.017]

Valproic Acid Induces Three Novel Cytotoxic Secondary Metabolites in Diaporthe sp., an Endophytic Fungus from Datura inoxia Mill

2018-04-10

[10.1016/j.bmcl.2018.04.018]

Agonists of the γ-Aminobutyric Acid Type B (GABAB) Receptor Derived from β-Hydroxy and β-Amino Difluoromethyl Ketones

2018-04-07

[10.1016/j.bmcl.2018.04.003]

Synthesis of 3-(3-hydroxyphenyl)pyrrolidine dopamine D3 receptor ligands with extended functionality for probing the secondary binding pocket

2018-04-04

[10.1016/j.bmcl.2018.03.084]

More Articles...